Applied DNA Sciences Inc. held its annual meeting of stockholders on May 22, 2025. The proposals included the election of six directors, which was approved. The appointment of CBIZ CPAs P.C. as the independent registered public accounting firm for the fiscal year ending September 30, 2025, was ratified. An amendment to the company's certificate of incorporation to authorize a reverse stock split was granted discretionary authority for 12 months. An amendment to the 2020 Equity Incentive Plan to increase the number of authorized shares was approved.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.